Sichuan Goldstone Asia Pharmaceutical Inc.

    Jurisdiction
    China
    ISIN
    CNE100001YX5 (300434.SZ)
    Sectors
    1. Industrials
    2. Industrial - Distribution

    Scores

    Fair value (Benjamin Graham formula)
    N/A
    Financial strength (Piotroski F-Value)
    5 / 9
    Fundamental strength relative to industry (Mohanram G-Value)
    1 / 7

    Profile

    Sichuan Goldstone Asia Pharmaceutical Inc. engages in the research, development, manufacture, and sale of medicines and health products in China and internationally. Read full profile

    Fundamentals

    Net revenue
    €127.56M
    Gross margin
    57.5%
    EBIT
    €17.04M
    EBIT margin
    13.4%
    Net income
    €14.08M
    Net margin
    11.0%

    Statement period: - (published )

    Stock price

    Stock price loading... No stock price available Stock price provided by Lang & Schwarz Steigende Zinsen und niedrigere Bewertungen für Wachstumsaktien im Allgemeinen Eine Gewinnwarnung beim Konkurrenten Adyen signalisiert eine Abkühlung des europäischen Markts für Zahlungsdienstleistungen. Eine Gewinnwarnung von Wordline SA triggert einen massiven Kursverlust.

    Configure chart

    Adjust colors to be more accessible for red-green-colorblind users.
    Scale
    Moving average Display a moving average line on the chart.

    Dividends

    Last dividend amount
    CN¥0.07
    Ex date
    Payment date
    Dividend payout ratio
    24.4%

    Analyst ratings

    No analyst ratings available

    Insider Transactions

    No insider transactions in the last 90 days. View older insider transactions

    Earnings Calls

    Add to watchlist

    Notifications